Home / Levodopa, Decarboxylase Inhibitor and COMT Inhibitor / Czechia
CZ ATC N04BA03 · updated 2 Nov 2026
Levodopa, Decarboxylase Inhibitor and COMT Inhibitor shortage in Czechia
Is there a Levodopa, Decarboxylase Inhibitor and COMT Inhibitor shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Levodopa, Decarboxylase Inhibitor and COMT Inhibitor product is reported short in Czechia, the first since 11 Sep 2026. The company estimate for the return is 20 Nov 2026. Main reason: manufacturing problem.
Also short in Italy, Spain, Sweden. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | CORBILTA 100MG/25MG/200MG 100MG/25MG/200MG TBL FLM 100 | Orion Corporation, Espoo | 11 Sep 2026 | 20 Nov 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.